Finland· FI-REL-REL8289
Novantrone
A mitoxantrone product, registered in Finland by LEDERLE. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Mitoxantrone is registered in 14 of 19 countries.
Countries holding a registration under ATC L01DB07 (mitoxantrone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Mitoxantrone · ATC L01DB07
14 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Manufacturer
- LEDERLE
- Country
- Finland (FI)
- ATC code
- L01DB07
- ATC class
- Mitoxantrone
- Defined daily dose
- 10 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
405 interactions on record for mitoxantrone.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mitoxantrone · interactions on record
405 records
- 31 severe
- 199 moderate
- 15 minor
- 160 info
Most severe, free to view
- DolasetronA04AA04severe
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01DB07
Mitoxantrone, as other registers publish it.
- DenmarkMitoxantron "Ebewe"Ebewe Pharma Ges.m.b.H. Nfg. KG
- FinlandMitoxantron AccordAccord Healthcare B.V.
- NetherlandsMitoxantron Accord 2 mg/ml, concentraat voor oplossing voor infusieAccord Healthcare B.V.
- FinlandMitoxantron EbeweEbewe Pharma Ges.m.b.H. Nfg.KG
- NorwayMitoxantron EbeweEBEWE Pharma Ges.m.b.H Nfg. KG
- FinlandMitoxantron EbeweParanova Oy
- SwedenMitoxantron Ebewe 2 mg/ml Koncentrat till infusionsvätska, lösningEBEWE Pharma Ges.m.b.H.Nfg.KG
- PolandMitoxantron SandozSandoz GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a844bf32-1fc5-4825-9315-0c6092bcded6 GET /v1/drugs/a844bf32-1fc5-4825-9315-0c6092bcded6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "infuusiokonsentraatti",
"route": null,
"ddd_unit": null,
"strength": "2 mg/ml",
"atc_label": "mitoksantroni",
"ma_number": "9955",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL8289",
"authorised_at": "1989-04-05"
}See everything about mitoxantrone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.